DK585684D0 - Praeparat af nucleinsyrekomponenter - Google Patents

Praeparat af nucleinsyrekomponenter

Info

Publication number
DK585684D0
DK585684D0 DK585684A DK585684A DK585684D0 DK 585684 D0 DK585684 D0 DK 585684D0 DK 585684 A DK585684 A DK 585684A DK 585684 A DK585684 A DK 585684A DK 585684 D0 DK585684 D0 DK 585684D0
Authority
DK
Denmark
Prior art keywords
preparation
nucleic acid
acid components
components
nucleic
Prior art date
Application number
DK585684A
Other languages
English (en)
Other versions
DK585684A (da
DK166601B1 (da
Inventor
Shohei Ogoshi
Original Assignee
Otsuka Pharma Co Ltd
Ajinomoto Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd, Ajinomoto Kk filed Critical Otsuka Pharma Co Ltd
Publication of DK585684D0 publication Critical patent/DK585684D0/da
Publication of DK585684A publication Critical patent/DK585684A/da
Application granted granted Critical
Publication of DK166601B1 publication Critical patent/DK166601B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
DK585684A 1983-12-09 1984-12-07 Praeparat af nucleinsyrekomponenter til parenteral indgivelse DK166601B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP58233142A JPS60126220A (ja) 1983-12-09 1983-12-09 核酸成分組成物
JP23314283 1983-12-09
JP4324216A JPH0662422B2 (ja) 1983-12-09 1992-12-03 核酸成分組成物
JP32421692 1992-12-03

Publications (3)

Publication Number Publication Date
DK585684D0 true DK585684D0 (da) 1984-12-07
DK585684A DK585684A (da) 1985-06-10
DK166601B1 DK166601B1 (da) 1993-06-21

Family

ID=26530870

Family Applications (1)

Application Number Title Priority Date Filing Date
DK585684A DK166601B1 (da) 1983-12-09 1984-12-07 Praeparat af nucleinsyrekomponenter til parenteral indgivelse

Country Status (9)

Country Link
US (1) US4758553A (da)
EP (1) EP0149775B1 (da)
JP (2) JPS60126220A (da)
CA (1) CA1258632A (da)
CH (1) CH671497A5 (da)
DK (1) DK166601B1 (da)
FR (1) FR2560045B1 (da)
GB (1) GB2152814B (da)
IT (1) IT1180633B (da)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049372A (en) * 1982-07-13 1991-09-17 Eliezer Rapaport Anticancer activities in a host by increasing blood and plasma adenosine 5'-triphosphate (ATP) levels
JPS6117516A (ja) * 1984-07-04 1986-01-25 Morishita Seiyaku Kk ヌクレオシド含有輸液
JPH0669953B2 (ja) * 1985-08-16 1994-09-07 日産化学工業株式会社 脳脊髄系神経栄養剤
US5246708A (en) * 1987-10-28 1993-09-21 Pro-Neuron, Inc. Methods for promoting wound healing with deoxyribonucleosides
KR890701609A (ko) * 1987-10-28 1989-12-21 원본미기재 아실 데옥시리보뉴클레오시드 유도체 및 그의 사용
US6020322A (en) * 1993-11-09 2000-02-01 Pro-Neuron, Inc. Acyl deoxyribonucleoside derivatives and uses thereof
US6919320B1 (en) 1987-10-28 2005-07-19 Wellstat Therapeutics Corporation Pharmaceutical compositions containing deoxyribonucleosides for wound healing
US6348451B1 (en) 1987-10-28 2002-02-19 Pro-Neuron, Inc. Acyl deoxyribonucleoside derivatives and uses thereof
US6743782B1 (en) 1987-10-28 2004-06-01 Wellstat Therapeutics Corporation Acyl deoxyribonucleoside derivatives and uses thereof
US5268365A (en) * 1988-03-11 1993-12-07 Rudolph Frederick B Nucleotides, nucleosides, and nucleobases in immune function restoration enhancement or maintenance
GB2216416B (en) * 1988-03-11 1992-06-24 Sandoz Ltd Nucleobase source for the stimulation of the immune system
SU1575359A1 (ru) * 1988-06-14 1991-05-15 Институт Морфологии Человека Амн Ссср Способ получени рибонуклеотидов
FR2634374B1 (fr) * 1988-07-19 1993-10-15 Laboratoires Serobiologiques Agents photoprotecteurs, cytophotoprotecteurs cutanes ayant une activite photoprotectrice des cellules constitutives, fonctionnelles de la peau, en particulier des cellules de langerhans, a base de composes nucleiques : nucleoprotides, ribonucleotides et desoxyribonucleotides, ribonucleosides et desoxyribonucleosides, compositions cosmetiques ou dermo-pharmaceutiques contenant un tel agent ainsi que des nouveaux composes en soi
US7169765B1 (en) 1988-10-27 2007-01-30 Wellstat Therapeutics Corporation Acyl deoxyribonucleoside derivatives and uses thereof
US5231085A (en) * 1988-10-31 1993-07-27 Sandoz Ltd. Compositions and methods for the enhancement of host defense mechanisms
DE58902899D1 (de) * 1988-12-14 1993-01-14 Ciba Geigy Ag 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
JPH02204489A (ja) * 1989-02-02 1990-08-14 Ajinomoto Co Inc 易溶性２’，３’―ジデオキシイノシン、その製造法及び２’，３’―ジデオキシイノシン水性溶液の製造法
US5576351A (en) * 1989-12-29 1996-11-19 Mcgaw, Inc. Use of arginine as an immunostimulator
DE4102240C1 (da) * 1991-01-24 1992-04-09 Birkmayer, Joerg, Univ.-Prof. Ddr., Wien, At
US5320846A (en) * 1991-04-17 1994-06-14 New England Deaconess Hospital Corp. Method and composition for testing patients with metabolic depleting diseases
US5292498A (en) * 1991-06-19 1994-03-08 The University Of North Carolina At Chapel Hill Method of treating lung disease with uridine triphosphates
USH1637H (en) * 1991-09-18 1997-03-04 Offord; Bruce W. Laser-assisted fabrication of bipolar transistors in silicon-on-sapphire (SOS)
US5264220A (en) * 1991-11-12 1993-11-23 Long David M Jr Method of extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents
JP3173844B2 (ja) * 1992-03-03 2001-06-04 雪印乳業株式会社 生体組織内ω３系脂肪酸増加剤及びそれを含む栄養組成物
US5780039A (en) * 1992-04-23 1998-07-14 Novartis Nutrition Ag Orally-ingestible nutrition compositions having improved palatability
AU713021B2 (en) * 1992-10-09 1999-11-18 University Of North Carolina At Chapel Hill, The Method of treating lung disease with uridine triphosphates
US5422343A (en) * 1992-12-21 1995-06-06 Otsuka Pharmaceutical Factory, Inc. Prophylactic and therapeutic composition for MRSA infection
US5852000A (en) * 1993-08-25 1998-12-22 Otsuka Pharmaceutical Factory, Inc. Cardiac rehabilitation agent
US5492899A (en) * 1994-01-10 1996-02-20 Abbott Laboratories Infant nutritional formula with ribo-nucleotides
US6136858A (en) 1994-01-10 2000-10-24 Abbott Laboratories Infant formula and methods of improving infant stool patterns
US5700590A (en) * 1994-01-10 1997-12-23 Abbott Laboratories Nutritional formula with ribo-nucleotides
US5488039A (en) * 1994-01-10 1996-01-30 Abbott Laboratories Method for the production of an enteral formula containing ribo-nucleotides
US5602109A (en) * 1994-01-10 1997-02-11 Abbott Laboratories Method to enhance the immune system of a human
US20030026782A1 (en) * 1995-02-07 2003-02-06 Arthur M. Krieg Immunomodulatory oligonucleotides
US5968913A (en) * 1996-07-03 1999-10-19 Inspire Pharmaceuticals, Inc. Pharmaceutical compositions of uridine triphosphate
JP2002521451A (ja) * 1998-07-31 2002-07-16 エイチエムイー エンタープライゼズ，リミテッド ライアビリティ カンパニー 抗酸化物質組成物及び該組成物を用いて疾患を処理する方法
US6977245B2 (en) 1999-04-12 2005-12-20 The United States Of America As Represented By The Department Of Health And Human Services Oligodeoxynucleotide and its use to induce an immune response
NZ518305A (en) * 1999-10-13 2004-08-27 Ewos Ltd Fish feed with increased nucleotide content
WO2001051500A1 (en) * 2000-01-14 2001-07-19 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Oligodeoxynucleotide and its use to induce an immune response
EP1372641A4 (en) * 2001-03-05 2004-08-25 Stephen P Ernest ENTERAL FORMULATION
US7666674B2 (en) 2001-07-27 2010-02-23 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo
AU2002361468A1 (en) 2001-08-14 2003-03-18 The Government Of The United States Of America As Represented By The Secretary Of Health And Human S Method for rapid generation of mature dendritic cells
US8466116B2 (en) 2001-12-20 2013-06-18 The Unites States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of CpG oligodeoxynucleotides to induce epithelial cell growth
US7615227B2 (en) * 2001-12-20 2009-11-10 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of CpG oligodeoxynucleotides to induce angiogenesis
US7345028B1 (en) * 2002-06-14 2008-03-18 Youssef Nazih R Energy-protective composition comprising adenosine phosphates
US6916795B1 (en) * 2002-06-14 2005-07-12 N.R. Youssef, Llc Energy-protective composition comprising adenosine phosphates
US8263091B2 (en) * 2002-09-18 2012-09-11 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides
EP1908492A4 (en) * 2005-06-22 2008-12-10 Ajinomoto Kk METABOTROPIC GLUTAMATE RECEPTOR ACTIVATOR
ATE509624T1 (de) 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
CN102481009A (zh) * 2009-08-13 2012-05-30 雀巢产品技术援助有限公司 包含外源性核苷酸的营养组合物
CN112340649B (zh) * 2020-11-04 2022-06-17 湖南长乐建材有限公司 一种移动式液压举升油管枕

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2786051A (en) * 1952-04-18 1957-03-19 American Home Prod Growth-promoting substances and their recovery
US3231385A (en) * 1960-12-29 1966-01-25 Takeda Chemical Industries Ltd Dairy products
US3686392A (en) * 1965-01-27 1972-08-22 Takeda Chemical Industries Ltd Nutrient ration for increasing growth of livestock and poultry

Also Published As

Publication number Publication date
CA1258632A (en) 1989-08-22
DK585684A (da) 1985-06-10
DK166601B1 (da) 1993-06-21
IT1180633B (it) 1987-09-23
US4758553A (en) 1988-07-19
JPS60126220A (ja) 1985-07-05
JPH0662422B2 (ja) 1994-08-17
FR2560045B1 (fr) 1988-08-19
EP0149775B1 (en) 1990-02-21
GB2152814A (en) 1985-08-14
FR2560045A1 (fr) 1985-08-30
CH671497A5 (da) 1989-09-15
JPH05320052A (ja) 1993-12-03
GB2152814B (en) 1987-12-09
EP0149775A1 (en) 1985-07-31
JPH0534337B2 (da) 1993-05-21
GB8430577D0 (en) 1985-01-09
IT8405242A0 (it) 1984-12-07

Similar Documents

Publication Publication Date Title
DK585684A (da) Praeparat af nucleinsyrekomponenter
DK224086A (da) Fremstilling af (threo)-1-aryl-2-acylamido-3-flour-1-propanoler
DK336783D0 (da) Fremgangsmade til fremstilling af methylendiphosphonsyrederivater
DK148885A (da) Stabilt praeparat af interleukin-2
DK205284D0 (da) Kompleksforbindelser af technetium-9m med alkylenaminoximer
DK427286A (da) Fremgangsmaade til fremstilling af tetrafluorbenzoesyre
DK147484D0 (da) Oparbejdning af polysaccharider
DK529583D0 (da) Enzymatisk fremstilling af l-serin
TR22146A (tr) Difloropiridin bilesiklerinin hazirlanmasi
DK280285A (da) Fremgangsmaade til fremstilling af ascorbinsyre
DK38593A (da) Alkoxymethylethere af glyceroler
DK81584D0 (da) Syreresistente funktionelle vaesker af phosphatester
DK203384D0 (da) Immobilisering af proteiner
DK486985D0 (da) Fremgangsmaade til fremstilling af tetrahydrofolinsyre
DK547488A (da) Fremgangsmaade til fremstilling af pyrodruesyre
DK496183D0 (da) Fremgangsmade til fremstilling af nitroalkaner
DK175587A (da) Fremstilling af substituerede (dichlormethyl)-pyridiner
DK345683A (da) Fremstilling af 2-t-butyl-5-chlorpyrimidin
DK135387D0 (da) Fremstilling af proteiner
DK71884D0 (da) Fremgangsmade til fremstilling af sulfonamidgruppeholdige aryloxybenzoesyre-derivater
DK156388C (da) Fremgangsmaade til fremstilling af nitroalkaner
DK225384D0 (da) Bis-alkylphosphoniumsalte af n-phosphonomethylglycin
DK343981A (da) Fremstilling af 3,5-dimethyl-4-pentensyre
DK365185D0 (da) Fremstilling af erythropoietin.
DK524384D0 (da) Alkoxyiminoetherderivater af 5-acyl-2(1h)-pyridinoner

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired